INCLISIRAN A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZE

Project: Research project

Project Details

Description

INCLISIRAN A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE EFFECT OF 300 MG OF INCLISIRAN SODIUM GIVEN AS SUBCUTANEOUS INJECTIONS IN SUBJECTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) AND ELEVATED LOW-DENSITY LIPOPROTEIN
StatusFinished
Effective start/end date11/1/173/30/18

Funding

  • THE MEDICINES COMPANY

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.